ARCHIVES

In Brief: $100 Million Being Spent On Interferon In U.S., Rauscher Says; DeVita; Criticism Deserved

This article is from The Cancer Letter archive.

Vol. 06 No. 14 | April 4, 1980

Download PDF Visit The Full Archive

Related Articles

In Brief: Rogers Indicates He May Let Training Grant Bill Die

March 29, 1974

FDA unlikely to pull Iressa from market. Iressa a case study in how not to develop a drug, ODAC member says.

April 1, 2005

Fisher To Direct Wilmot CC

October 5, 2001

In Brief: MSK Opens Laurence Rockefeller Pavilion; Bush Event raised 410 Million for Anderson

July 9, 1999

In Brief: Rhoads Renamed Cancer Advisory Board Chairman; L-B’s Frederick Contract Renewed For $12 Million

June 28, 1974

NCCS Networker Volume 5 Issue 4, Fall 1991

September 13, 1991